Honoeye Falls, NY, United States of America

Patrick Leo

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Honoeye Falls, NY (US) (2020)
  • Honeoye Falls, NY (US) (2022 - 2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Patrick Leo**

Introduction

Patrick Leo, an accomplished inventor based in Honeoye Falls, NY, has made significant contributions to the field of prostate cancer research. With a total of three patents to his name, his innovative work focuses on enhancing the prediction and prognosis of prostate cancer recurrence.

Latest Patents

One of Patrick Leo’s latest patents, titled "Population-specific prediction of prostate cancer recurrence based on stromal morphology features," presents embodiments that facilitate the determination of a patient's probability of prostate cancer recurrence-free survival. The process involves accessing a digitized histological image of a prostate, identifying the nuclei of intra-tumoral stromal cells, and generating a probability score based on extracted features. Another notable patent, "Prognosis of prostate cancer with computerized histomorphometric features of tumor morphology from routine hematoxylin and eosin slides," outlines a method for generating a biochemical recurrence (BCR) prognosis by analyzing digitized tissue images. This patent emphasizes the segmentation of gland lumens using a deep learning model and the extraction of quantitative histomorphometry features to classify patients as high-risk or low-risk for BCR.

Career Highlights

Patrick Leo is affiliated with Case Western Reserve University, where he applies his expertise to advance medical diagnostics and cancer research. His innovative approaches have the potential to significantly influence how prostate cancer is assessed and treated, demonstrating his commitment to improving patient outcomes.

Collaborations

Throughout his career, Patrick has collaborated with esteemed colleagues, including Anant Madabhushi and Andrew Janowczyk. These partnerships have enriched his research and contributed to the development of state-of-the-art methodologies in prostate cancer analysis.

Conclusion

In conclusion, Patrick Leo stands out as a key innovator in the field of prostate cancer research. With his groundbreaking patents and collaborative efforts, he continues to push the boundaries of medical technology, fostering advancements that aim to improve diagnostic accuracy and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…